Safety and immunogenicity of investigational tuberculosis vaccine M72/AS01E-4 in people living with HIV in South Africa: an observer-blinded, randomised, controlled, phase 2 trial.

GSK692342 - GSK, Bill & Melinda Gates Foundation

http://www.ncbi.nlm.nih.gov/pubmed/40614747

Alemnew F Dagnew; Alexander C Schmidt; Amy Cinar; Daniel Bower; James C Innes; Jintanat Ananworanich; Keren Middelkoop; Kogieleum Naidoo; Lee Fairlie; Linda L Han; Lisa Schlehuber; Michael Dunne; Michele Tameris; Nicole Frahm; Robert J Wilkinson

Jul 5, 2025